Matthew Calistri | Vice President of Investor Relations |
Tony Coles | Chairperson & Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Mark Bodenrader | Interim Chief Financial Officer |
Paul Matteis | Stifel |
Good morning. Welcome to the Cerevel Therapeutics Third Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask a question during the Q&A portion of the call. Please note that this call maybe recorded.